Apixaban effectively lowers the risk of ischemic stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Systemic exposure to a given apixaban dose depends on multiple clearance pathways. | Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways